A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
2020 · Journal of the American Society of Nephrology · 168 citations
https://doi.org/10.1681/asn.2020071106
J
Jakob Mühlbacher
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
598
Citations
11
h-index
14
i10-index
Jakob Mühlbacher is an academic researcher from Vienna General Hospital. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Pancreatic and Hepatic Oncology Research & Complement system in diseases. The author has an h-index of 11, co-authored 33 publications.
ORCID: 0000-0002-8592-8259Papers by this author
worksClazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
2019 · Trials · 64 citations
https://doi.org/10.1186/s13063-018-3158-6
Feasibility of ultrasound measurement in a human model of acute compartment syndrome
2019 · World Journal of Emergency Surgery · 19 citations
https://doi.org/10.1186/s13017-019-0222-9
Effect of Intraoperative Goal-Directed Fluid Management on Tissue Oxygen Tension in Obese Patients: a Randomized Controlled Trial
2020 · Obesity Surgery · 13 citations
https://doi.org/10.1007/s11695-020-05106-x
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena
2022 · Transplantation · 9 citations
https://doi.org/10.1097/tp.0000000000004285
Surgery for chronic pancreatitis: the comparison of two high-volume centers reveals lack of a uniform operative management
2021 · Langenbeck s Archives of Surgery · 5 citations
https://doi.org/10.1007/s00423-021-02335-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat